| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8771822 | The Journal of Urology | 2018 | 22 Pages |
Abstract
Brachytherapy is highly curative with stable prostate specific antigen at a surgical ablation level in 86% of patients. Rising prostate specific antigen is rare at a 6% incidence and often innocuous.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Audrey Tetreault-Laflamme, Juanita Crook, Jeremy Hamm, Tom Pickles, Mira Keyes, Michael McKenzie, Howard Pai, Francois Bachand, James Morris,